Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04597372 · ClinicalTrials.gov registry record · Phase 2
Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
A Phase 2 study of Urinary Retention Postoperative, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- Recruiting
- Registry status
- Phase 2
- Development phase
- 154
- Enrollment target
- 1
- Study location
NCT04597372 is a Phase 2 study of Urinary Retention Postoperative that is actively recruiting participants, run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute). The registered enrollment target is 154 participants, below the 23,408-participant average among 3 other Urinary Retention Postoperative trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04597372, a Phase 2 study of Urinary Retention Postoperative, is actively recruiting participants, sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute).
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 154 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG Tamsulosin
Study Locations (1)
Pennsylvania
- West Penn Hospital - Pittsburgh
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 154 participants |
| Start Date | 2021-11-03 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)34 total trials
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04597372
The ClinicalTrials.gov registry entry for NCT04597372 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 154 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 23,408-participant average among 3 other Urinary Retention Postoperative trials with a reported enrollment target (99% lower). The listed sponsor is Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Urinary Retention Postoperative appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT04597372 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04597372 about?
NCT04597372 is a clinical study titled "Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery". The objective of the study is to determine the effectiveness of postoperative Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) following pelvic reconstructive surgery through a double blind, randomized placebo-controlled trial.
What is the current status of trial NCT04597372?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 154 participants. The study started on 2021-11-03. Estimated completion is 2026-12.
What conditions does trial NCT04597372 study?
This clinical trial studies the following conditions: Urinary Retention Postoperative.
What interventions are being tested in trial NCT04597372?
The interventions under investigation include: Placebo (DRUG), Tamsulosin (DRUG).
Who is sponsoring clinical trial NCT04597372?
This trial is sponsored by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute), which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04597372 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Urinary Retention Postoperative
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Uroselective Alpha-1-Antagonist to Reduce the Incidence and Duration of Postoperative Urinary Retention Following Spine Surgery
RECRUITING · Phase 4
-
NMBA Reversal and Postoperative Urinary Retention
ACTIVE NOT RECRUITING
-
Strict Need to Void After Same-day Discharge, Non-urogynecologic, Minimally Invasive Hysterectomy
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.